Lv21
138 积分 2023-10-12 加入
Bioactive Products Targeting C-Met As Potential Antitumour Drugs
25天前
已完结
Bioactive Products Targeting C-Met As Potential Antitumour Drugs
1个月前
已完结
HGF/c‐Met Promotes Breast Cancer Tamoxifen Resistance Through the EZH2/HOTAIR‐miR‐141/200a Feedback Signaling Pathway
1个月前
已完结
Development and Challenge of Fluorescent Probes for Bioimaging Applications: From Visualization to Diagnosis
4个月前
已完结
Lysine-Targeted Inhibitors and Chemoproteomic Probes
4个月前
已完结
Chemoproteomics and Chemical Probes for Target Discovery
4个月前
已完结
Ligand discovery by activity-based protein profiling
6个月前
已完结
Does c-Met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer?
8个月前
已完结
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
8个月前
已完结
Savolitinib: First Approval
9个月前
已完结
皖公网安备34019202002308
